142 related articles for article (PubMed ID: 25389765)
1. Trantinterol, a novel β2-adrenoceptor agonist, noncompetitively inhibits P-glycoprotein function in vitro and in vivo.
Wang T; Sun Y; Ma W; Yang Z; Yang J; Liu J; Fan H; Yang Y; Gu J; Fawcett JP; Guo Y
Mol Pharm; 2015 Jan; 12(1):1-9. PubMed ID: 25389765
[TBL] [Abstract][Full Text] [Related]
2. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
4. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
Tang F; Ouyang H; Yang JZ; Borchardt RT
J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of P-Glycoprotein Mediated Efflux in Caco-2 Cells by Phytic Acid.
Li L; Fu Q; Xia M; Xin L; Shen H; Li G; Ji G; Meng Q; Xie Y
J Agric Food Chem; 2018 Jan; 66(4):988-998. PubMed ID: 29282978
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption.
Dey S; Gunda S; Mitra AK
J Pharmacol Exp Ther; 2004 Oct; 311(1):246-55. PubMed ID: 15175422
[TBL] [Abstract][Full Text] [Related]
8. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
10. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
[TBL] [Abstract][Full Text] [Related]
11. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
[TBL] [Abstract][Full Text] [Related]
12. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of trantinterol and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry.
Li K; Wang Y; Zhang L; Qin F; Guo X; Li F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 934():89-96. PubMed ID: 23911540
[TBL] [Abstract][Full Text] [Related]
14. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates.
Ozgür B; Saaby L; Langthaler K; Brodin B
Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N
Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100
[TBL] [Abstract][Full Text] [Related]
17. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Bharate JB; Singh S; Wani A; Sharma S; Joshi P; Khan IA; Kumar A; Vishwakarma RA; Bharate SB
Org Biomol Chem; 2015 May; 13(19):5424-31. PubMed ID: 25865846
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers.
de Souza J; Benet LZ; Huang Y; Storpirtis S
J Pharm Sci; 2009 Nov; 98(11):4413-9. PubMed ID: 19472342
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: implications for intestinal pH and effects on drug absorption.
Mitra P; Audus K; Williams G; Yazdanian M; Galinis D
J Pharm Sci; 2011 Oct; 100(10):4258-68. PubMed ID: 21538355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
